BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Holistic medicine
,
Quercetin
,
rs2230926
,
CXCL2
,
Angiogenesis
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TIE1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Omental adipose tissue
Lung
Fetal lung
Heart ventricle
Adipose tissue subcutaneous
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
11p partial monosomy syndrome
Lymphedema
Lung cancer
Musculoskeletal function
Viral carditis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
SB 202190
HGF protein, human
tat Gene Products, Human Immunodeficiency Virus
Thimerosal
phorbolol-12-myristate-13-acetate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Tnfaip6
ZSCAN25
SOX6
RNR1
FOXF2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.
Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.
Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a …
A novel cis-regulatory variant modulating TIE1 expression associated with attention deficit hyperact…
Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stag…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ